One of many troubling complications of infection with the SARS-CoV-2 coronavirus is its ability to trigger the formation of multiple blood clots, said Francis S. Collins, M.D., Ph.D.
It raises the question of whether and when more aggressive blood-thinning treatments might improve outcomes for people hospitalized for COVID-19, continued Dr. Collins’s blog published on February 2, 2021.
The answer to this question is desperately needed to help guide clinical practice.
Read More
